Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations

12.12.2022 - As mental health disorders increasingly impact global populations, Gb Sciences is developing psychotropic but non-psychedelic treatments for anxiety and depression that compete with the emerging billion-dollar psychedelic companies.LAS VEGAS, Dec. ... Seite 1

Related Keywords

,Gb Sciences ,Gb Sciences Inc ,Phytomedical Analytics For Research Optimization At Scale ,Andrea Small Howard ,Chief Science Officer ,Phytomedical Analytics ,Research Optimization ,